...
THCLARGE

Tenet Healthcare Corporation

HealthcareMedical - Care Facilities
$239.39
$0.00(-0.12%)
52W$109.82
$240.57
FinancialsValuationvs HCA
Updated Mar 2, 12:00 AM
RSI75
RS Rating79/99
Beta0.93
Volatility43%
F-Score7/9
Mkt Cap$21.0B
STAGE 2 UPTREND

Price Action

5Y Daily
50 DMA150 DMA200 DMA

Technical Summary

STAGE 2 UPTREND

Tenet Healthcare Corporation is in a confirmed Stage 2 uptrend, with price holding above all major moving averages and trend structure remaining intact. Relative strength is moderate (RS Rating: 79), indicating performance broadly in line with the market. Earnings growth of 27% provides fundamental context to the price action. Momentum will need to be maintained above the 50-day moving average to sustain this leadership phase.

Relative Strength
79
out of 99
Average
Trend Score
4/4
Minervini Criteria
STAGE 2 UPTREND
Risk (Beta)
0.93
vs S&P 500
MARKET
52W Position
99%
from 52W low
Near High
Trend & Momentum Analysis

Trend Template (Minervini)

STAGE 2 UPTREND4/4 Criteria Met
CriterionValueStatus
Price > 50 SMA$204.95
50 SMA > 100 SMA$203.88
100 SMA > 150 SMA$196.66
150 SMA > 200 SMA$189.48

Price vs Moving Averages

PeriodValueSpreadSignal
20 SMA$217.04+10.30%ABOVE
50 SMA$204.94+16.81%ABOVE
100 SMA$203.88+17.42%ABOVE
150 SMA$196.66+21.73%ABOVE
200 SMA$189.48+26.34%ABOVE

Price Performance

1D-0.1%
1W+2.4%
1M+26.3%
3M+10.4%
6M+29.7%
YTD+20.0%
1Y+89.1%
3Y+59.9%
52-Week Trading Range99% from low
$239.39
52W Low$109.82
52W High$240.57

Technical Indicators

RSI (14)OVERBOUGHT
74.5
305070
VCP ScoreHOT
9/10
Base depth: 23.2%

Risk Profile

Beta
0.93
52W Vol
43%
ATR
$9.16
Max DD (1Y)
-20%

Volume Analysis

Today
239
50D Avg
825.7K
Vol Ratio
0.00x
Liquidity
LIQUID

Earnings Momentum

Q1'25-80%
$4.27
Q2'25+19%
$3.14
Q3'25-21%
$3.86
Q4'25+27%
$4.22
Fundamentals & Growth

Growth Trends

Compounded Sales Growth

10 Years:+1.35%
5 Years:+3.85%
3 Years:+3.58%
TTM:+3.12%

Compounded Profit Growth

10 Years:—
5 Years:+32.80%
3 Years:+59.88%
TTM:-51.94%

Stock Price CAGR

10 Years:+25.44%
5 Years:+35.26%
3 Years:+59.92%
1 Year:+89.11%

Return on Equity

10Y Avg:8.9%
5Y Avg:21.7%
3Y Avg:24.6%
Last Year:15.7%

Key Metrics

Market Cap$21.0B
Gross Margin41.4%
Net Margin6.6%
Piotroski F-Score7/9

More THC Analysis

Full Financial AnalysisDCF & Intrinsic ValueTotal Return Calculator

Compare With

THC vs HCAHCAMPWACHCARDT

Data Dictionary

RS Rating (Relative Strength)

Measures 12-month price performance vs all stocks. Rating of 79 meansTHC outperformed 79% of all stocks. Scores >80 indicate market leaders.

Beta

Measures volatility vs S&P 500. Beta of 0.93 means 7% less volatile than market.

Piotroski F-Score

9-point financial strength score based on profitability, leverage, and efficiency. Score of 7/9. Scores 7-9 = strong, 4-6 average, 0-3 = weak.

VCP (Volatility Contraction Pattern)

Measures base formation quality. Higher scores indicate tighter consolidation near pivot points. Score of 9/10 with HOT status.

Frequently Asked Questions

Is THC in an uptrend right now?

THC has a trend score of 4/4 based on Minervini's Stage Analysis. Yes, THC is in a Stage 2 uptrend with price above all major moving averages (50, 100, 150, 200 SMA) properly stacked.

Is THC overbought or oversold?

THC's RSI (14) is 75. The stock is in overbought territory (RSI > 70), which may signal a pullback.

Is THC outperforming the market?

THC has a Relative Strength (RS) Rating of 79 out of 99. THC is performing about average compared to the market.

Where is THC in its 52-week range?

THC is trading at $239.39, which is 100% of its 52-week high ($240.57) and 99% above its 52-week low ($109.82).

How volatile is THC?

THC has a Beta of 0.93 and 52-week volatility of 43%. It's less volatile than the S&P 500 - generally more stable.